Cannabidiol Supplement (CBD)

Dr. Serge presents Calmè

At Mind & Body Solutions, we meticulously choose our product offering based on  high quality, potency and transparency.

Calmè is the result of months of testing and research different types of CBD oil.  Our oil, derived from hemp, has been tested by a third-party lab and is free of pesticides, heavy metals, solvent and microbes.

Calmè has:

  - Low temperature organic hemp extraction

  - Full spectrum cannabinoid

  - Synergistic lipid formula

  - Lab tested; quantitative & qualitative analysis

  - Transparent labeling

The most wanted CBD oil on the market

Improve Anxiety

Sleep better

Pain Management

Calmè By Dr. Serge   630 mg/1260 mg    $55.00/$95.00

     Available in our office


CBD stands for cannabidiol. It is the second most common ingredients found in cannabis. While CBD is an essential component of marijuana, it is extracted directly from the hemp plant not the marijuana plant.

 CBD on his own does not cause any psychotic effect.  To date, there is no evidence of long term health issue associated with the use of pure CBD.

Texas removed cannabidiol with 0.3% or less of THC ( psychoactive component) from its Schedule I controlled substances list in June of 2019 with the passage of House Bill 1325. As a result, licensed retailers may sell some hemp products with CBD if they also contain the THC within the legal limit. Also., the state allows patients with certain medical conditions to use other medical formulations that contain CBD with less than 0.5% THC.

Unfortunately, just like any herbs, vitamins and other supplements, quality and purity vary tremendously.  As CBD oil became popular and very profitable, opportunist organizations jumped on the occasion.  The results? Impotent extracts and mediocre outcomes.

A project funded by Johns Hopkins University School of Medicine concluded that:

Results | Of 75 products purchased (47 different brands), 17% were accurately labeled, 23%were underlabeled, and 60%were overlabeled with respect to THC content (Table 1). The greatest likelihood of obtaining underlabeled products was in Los Angeles and overlabeled products in Seattle (χ2 = 12.94,P = .01). Non-THC content was generally low (Table 2). Forty-four products (59%) had detectable levels of CBD; only 13 had CBD content labeled. Four products were underlabeled and 9 were overlabeled for CBD. The median THC:CBD ratio of products with detectable CBD was 36:1, 7 had ratios of less than 10:1, and only 1 had a 1:1 ratio.